| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.041 | 0.8 |